Burueva, Dudari B. http://orcid.org/0000-0002-6077-5487
Kozinenko, Vitaly P. http://orcid.org/0000-0003-4101-6706
Sviyazov, Sergey V. http://orcid.org/0000-0002-8555-8403
Kovtunova, Larisa M. http://orcid.org/0000-0003-0922-6594
Bukhtiyarov, Valerii I. http://orcid.org/0000-0003-4382-1207
Chekmenev, Eduard Y. http://orcid.org/0000-0002-8745-8801
Salnikov, Oleg G. http://orcid.org/0000-0003-2266-7335
Kovtunov, Kirill V. http://orcid.org/0000-0001-7577-9619
Koptyug, Igor V. http://orcid.org/0000-0003-3480-7649
Funding for this research was provided by:
Российский Фонд Фундаментальных Исследований (19-29-10003, 19-33-60045, 19-29-10028)
Ministry of Science and Higher Education of the Russian Federation (AAAA-A21-121011390011-4)
U.S. Department of Defense (W81XWH15-1-0271, W81XWH-20-10576)
National Heart, Lung, and Blood Institute (1 R21 HL154032-01)
National Science Foundation (CHE-1904780)
Article History
Received: 28 April 2021
Revised: 16 June 2021
Accepted: 20 June 2021
First Online: 14 July 2021
Declarations
:
: EYC declares a stake of ownership in XeUS Technologies LTD.